Year archive

CYCLOPHARM LIMITED — 2017 filings

All 55 regulatory filings released by CYCLOPHARM LIMITED (CYC) in 2017, sourced directly from the official regulator.

55 Filings

2017 Period

2017 filings (55)

Filing	Released	Lang
FNN Interview and Presentation 1 page 358.0KB Regulatory Filings	2017-12-20	English
Cyclopharm FNN Investor Event 31 pages 1.6MB Investor Presentation	2017-12-11	English
Change of Director's Interest Notice - D Heaney 2 pages 597.2KB Director's Dealing	2017-11-19	English
CYC CEO Presentation 2017 Australian Microcap Conference 25 pages 697.3KB Investor Presentation	2017-10-17	English
Technegas USFDA Clinical Trial - Patient Enrolment Underway 2 pages 497.5KB Regulatory Filings	2017-09-25	English
Cyclopharm acquires European distribution business 2 pages 102.4KB Capital/Financing Update	2017-09-19	English
Advancing Molecular Imaging in NSW 2 pages 124.3KB Capital/Financing Update	2017-09-18	English
Form 484 - cancellation of Long Term Incentive Plan shares 2 pages 10.5KB Share Issue/Capital Change	2017-09-07	English
Half Yearly Report and Accounts 41 pages 1.2MB Interim / Quarterly Report	2017-08-27	English
Dividend/Distribution - CYC 3 pages 26.4KB Notice of Dividend Amount	2017-08-27	English
Cyclopharm Limited 1H2017 Results Investor Presentation 24 pages 1.1MB Investor Presentation	2017-08-27	English
Nuclear imaging trial aiming to clear up airway diagnosis 2 pages 125.8KB Regulatory Filings	2017-08-17	English
CYC CEO To Present at Bioshares 2017 Biotech Conference 39 pages 1.2MB Investor Presentation	2017-07-20	English
Change in substantial holding - Barings Acceptance Limited 3 pages 1.1MB Regulatory Filings	2017-07-05	English
Change in substantial holding - Chemical Trustee Limited 3 pages 1.1MB Regulatory Filings	2017-07-05	English
Change of Director's Interest Notice - D Heaney 2 pages 199.2KB Director's Dealing	2017-07-03	English
Change of Director's Interest Notice - VGould 3 pages 223.6KB Director's Dealing	2017-07-03	English
Change of Director's Interest Notice - JMcBrayer 2 pages 197.9KB Director's Dealing	2017-07-03	English
Appendix 3B Final 8 pages 444.5KB Capital/Financing Update	2017-06-29	English
CYC Notification of Shortfall 1 page 29.0KB Capital/Financing Update	2017-06-27	English
CYC Entitlement Offer Closed 2 pages 612.9KB Capital/Financing Update	2017-06-27	English
Change of Director's Interest Notice 2 pages 136.3KB Director's Dealing	2017-06-22	English
CYC Entitlement Offer Booklet 54 pages 2.3MB Capital/Financing Update	2017-06-13	English
Entitlement Offer 29 pages 1.5MB Capital/Financing Update	2017-06-04	English
Cleansing Statement 1 page 110.9KB Capital/Financing Update	2017-06-04	English
Appendix 3B 8 pages 163.9KB Capital/Financing Update	2017-06-04	English
Letter to Eligible Shareholders 3 pages 147.4KB Capital/Financing Update	2017-06-04	English
Letter to Ineligible Shareholders 2 pages 155.9KB Capital/Financing Update	2017-06-04	English
Response to ASX query on Appendix 3Y 4 pages 625.9KB Director's Dealing	2017-06-01	English
CYC - Positive Results of China Clinical Trial 2 pages 70.7KB Capital/Financing Update	2017-05-31	English
Change of Director's Interest Notice 4 pages 764.1KB Director's Dealing	2017-05-30	English
CYC May 2017 Investor Presentation 29 pages 1.1MB Investor Presentation	2017-05-11	English
CYC 2017 AGM Presentation 30 pages 1.5MB AGM Information	2017-05-08	English
Chairman's Address to Shareholders 4 pages 117.6KB AGM Information	2017-05-08	English
Managing Director's Address to Shareholders 8 pages 175.5KB AGM Information	2017-05-08	English
Results of Meeting 2 pages 135.5KB Declaration of Voting Results & Voting Rights Announcements	2017-05-08	English
Announcement of buy-back - Appendix 3C 3 pages 124.1KB Transaction in Own Shares	2017-05-08	English
Final share buy-back notice - Appendix 3F 2 pages 133.8KB Transaction in Own Shares	2017-05-07	English
Appendix 3B 12 pages 677.8KB Capital/Financing Update	2017-04-18	English
Notice of Annual General Meeting/Proxy Form 19 pages 693.7KB AGM Information	2017-04-06	English
Initial Director's Interest Notice 2 pages 115.3KB Director's Dealing	2017-04-02	English
CYC Board Changes 2 pages 365.5KB Board/Management Information	2017-03-28	English
CYC Annual Report to Shareholders 110 pages 1.7MB Annual Report	2017-03-27	English
CYC Appendix 4G 10 pages 84.2KB Regulatory Filings	2017-03-27	English
Becoming a substantial holder - AACCF (Amended) 3 pages 310.0KB Regulatory Filings	2017-03-08	English
CYC 2016 Financial Year Results Investor Presentation 29 pages 1.3MB Investor Presentation	2017-03-05	English
Ceasing to be a substantial holder - Lloyds (Amended) 3 pages 1.5MB Regulatory Filings	2017-02-28	English
Cyclopharm Amended 2016 Preliminary Financial Report 69 pages 947.2KB Annual Report	2017-02-26	English
CYC-Record Revenues and Operating EBITDA, Final Div Declared 3 pages 405.9KB Earnings Release	2017-02-26	English
Preliminary Final Report 68 pages 1.1MB Annual Report	2017-02-21	English
Dividend/Distribution - CYC 3 pages 26.7KB Notice of Dividend Amount	2017-02-21	English
Ceasing to be a substantial holder - Lloyds 3 pages 1.2MB Regulatory Filings	2017-02-16	English
Becoming a substantial holder - AACCF 2 pages 779.6KB Regulatory Filings	2017-02-16	English
CYC 2016 PRELIMINARY HEADLINE UPDATE-RECORD RESULTS 2 pages 122.0KB Earnings Release	2017-02-05	English
Release Date of 2016 Full Year Preliminary Financial Results 1 Report Publication Announcement	2017-01-31	English

Filings by year

2026 47 filings
2024 69 filings
2023 39 filings
2022 33 filings
2021 84 filings
2020 40 filings
2019 37 filings
2018 32 filings
2017 55 filings
2016 33 filings
2015 37 filings
2014 20 filings
2013 36 filings
2012 38 filings
2011 40 filings
2010 19 filings
2009 30 filings
2008 49 filings
2007 39 filings